A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope and concerns about transparency and ethics.

The company brings together AI experts and experienced pharmaceutical scientists to build what Murdoch calls a “world-class drug design engine.” In 2024, Isomorphic signed major research deals ...